Regulating ferroptosis by roflumilast attenuates cisplatin-induced kidney injury
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114331 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Noha Abdel-Rahman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt. Electronic address: noha82@mans.edu.eg. Hauptthemen laut MEDLINE: Cisplatin, Ferroptosis, Benzamides, Aminopyridines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Mansoura University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt. Electronic address: noha82@mans.edu.eg.
- Department of Nephrology, Urology and Nephrology Center, Mansoura University, 35516 Mansoura, Egypt. Electronic address: amans83@mans.edu.eg.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt. Electronic address: maha_hesham@mans.edu.eg.
Förderung
- Mansoura University
Zitieren
APA
Abdel-Rahman, N., Abdel-Rahman, A. M., & Sharawy, M. H. (2025). Regulating ferroptosis by roflumilast attenuates cisplatin-induced kidney injury. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114331
Vancouver
Abdel-Rahman N, Abdel-Rahman AM, Sharawy MH. Regulating ferroptosis by roflumilast attenuates cisplatin-induced kidney injury. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114331
BibTeX
@article{AbdelRahman2025,
author = {Abdel-Rahman, Noha and Abdel-Rahman, Ahmed M and Sharawy, Maha H},
title = {Regulating ferroptosis by roflumilast attenuates cisplatin-induced kidney injury},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114331}
}
EUVIMED